Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.49 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | WNT3A | P56704 | 1/20 | 0.42 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1405144 | 0.91 | LMNA (0.58) | LMNAGAAKCNK3KCNK9CTNNB1 | |
| SCHEMBL20561314 | 0.87 | KCNK3 (0.45) | LMNAGAAKCNK3KCNK9F2 | |
| SCHEMBL27618282 | 0.87 | KAT6A (0.48) | LMNAGAAKCNK3KCNK9F2 | |
| SCHEMBL577104 | 0.82 | KCNK3 (0.41) | LMNAGAAKCNK3KCNK9F2 | |
| SCHEMBL322998 | 0.81 | LMNA (0.58) | LMNAF2POLBTSHRCES1 | |
| SCHEMBL6675290 | 0.81 | LMNA (0.51) | LMNAGAAKCNK3KCNK9CTNNB1 | |
| SCHEMBL10519876 | 0.80 | LMNA (0.58) | LMNAGAAKCNK3KCNK9CTNNB1 | |
| SCHEMBL29055923 | 0.79 | LMNA (0.56) | LMNAF2POLBTSHRCES1 | |
| SCHEMBL3717986 | 0.78 | GAA (0.56) | LMNAGAAKCNK3KCNK9POLB | |
| SCHEMBL31369140 | 0.78 | GAA (0.56) | LMNAGAAKCNK3KCNK9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079876-A | Fluopicola strain method for synthesizing amide | — | 2026-05-26 | — | — | CN | disclosed |
| EP-3635022-B1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA TEC LTD (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024010056-A1 | SECONDARY BATTERY | ダイキン工業株式会社 | 2024-01-11 | — | — | WO | disclosed |
| WO-2024010057-A1 | NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR COVERING BATTERY MATERIAL | ダイキン工業株式会社 | 2024-01-11 | — | — | WO | disclosed |
| WO-2023249003-A1 | SURFACE TREATMENT AGENT FOR ELECTRODE MATERIAL, POSITIVE ELECTRODE ACTIVE MATERIAL, CURRENT COLLECTOR FOIL, NEGATIVE ELECTRODE ACTIVE MATERIAL, CONDUCTIVE AID, ELECTRODE, BATTERY, METHOD FOR MANUFACTURING POSITIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CURRENT COLLECTOR FOIL, METHOD FOR MANUFACTURING NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CONDUCTIVE AID, AND METHOD FOR MANUFACTURING ELECTRODE | ダイキン工業株式会社 | 2023-12-28 | — | — | WO | disclosed |
| WO-2023238909-A1 | ELECTROLYTE SOLUTION AND SECONDARY BATTERY USING SAME | ダイキン工業株式会社 | 2023-12-14 | — | — | WO | disclosed |
| CN-114805188-B | Fluopicolide synthesis method | 利民化学有限责任公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116354830-A | Process for the preparation of functionalized fluorinated monomers, fluorinated monomers and compositions for the preparation thereof | 埃特纳科技有限公司 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023079988-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | 国立大学法人京都大学 | 2023-05-11 | — | — | WO | disclosed |
| CN-110770271-B | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-3145915-A1 | ANTIDIABETIC TRICYCLIC COMPOUNDS | Merck Sharp & Dohme Corp. (US) | 2017-03-29 | — | — | EP | disclosed |
| WO-2015176640-A1 | ANTIDIABETIC TRICYCLIC COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2015-11-26 | — | — | WO | disclosed |
| EP-1651604-B1 | N-´2-(2-PYRIDINYL)ETHYL BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER SAS (FR) | 2014-11-12 | — | — | EP | disclosed |
| US-7723364-B2 | N-[2-(2-pyridinyl) ethyl]benzamide compounds and their use as fungicides | BAYER CROPSCIENCE SA (FR) | 2010-05-25 | — | — | US | disclosed |
| US-20080154049-A1 | for acylation of an aromatic compound, comprising reacting an aromatic compound and an acylating agent of the carboxylic acid type, in the presence of a Lewis acid and of a silylated reagent selected from the group consisting of halosilanes and halosiloxanes. | SHASUN PHARMA SOLUTIONS LIMITED (GB) | 2008-06-26 | — | — | US | disclosed |
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | BAYER SAS (FR) | 2006-11-02 | — | — | US | disclosed |
| EP-1651604-A2 | N-¬2-(2-PYRIDINYL)ETHYL|BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | Bayer CropScience S.A. (FR) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005014545-A2 | N-′2-(2-PYRIDINYL) ETHYLBENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE S.A. (FR) | 2005-02-17 | — | — | WO | disclosed |
| EP-1500651-A1 | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides | Bayer CropScience S.A. (FR) | 2005-01-26 | — | — | EP | disclosed |
| US-4099014-A | BLOOD PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | CYP1A2, CYP4B1, CYP1B1 | LMNA 1980/4885GAA 175/4885KCNK3 1711/4885 |
| US-20080154049-A1 | for acylation of an aromatic compound, comprising reacting an aromatic compound and an acylating agent of the carboxylic acid type, in the presence of a Lewis acid and of a silylated reagent selected from the group consisting of halosilanes and halosiloxanes. | AADAC, APEH, DDC | LMNA 1577/4885GAA 615/4885KCNK3 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.